Verastem (VSTM) added ~14% on Thursday after Mizuho upgraded the stock arguing latest data for its cancer drug avutometinib could support accelerated nod. Read more here.
Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics First Quarter 2023 Financial Results Conference Call and Operational Progress.